Mordoh, José <br/><br/>
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study.  [electronic resource] 

 -  Frontiers in immunology  2017 
 - 625 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1664-3224 
<br/><br/><label>Standard No.: </label>10.3389/fimmu.2017.00625  doi